Future of flu vaccines. Expediting clinical trials in a pandemic.

Documenti analoghi

• Future of flu vaccines. Expediting clinical trials in a pandemic.
  di: Pollard, A, et al.
  Pubblicazione: (2009)
• Relationships between reactogenicity and age, dose number and immunogenicity in 937 children receiving two doses of ASO3(B)-adjuvanted split virion or whole virus H1N1 influenza A 2009 pandemic vaccines
  di: Walker, W, et al.
  Pubblicazione: (2011)
• Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study.
  di: Waddington, C, et al.
  Pubblicazione: (2010)
• Safety and immunogenicity of AS03 B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: Open label, randomised, parallel group, multicentre study
  di: Waddington, C, et al.
  Pubblicazione: (2010)
• Pandemic vaccine trials: expedite, but don’t rush
  di: Angus Dawson
  Pubblicazione: (2020-07-01)